These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23829173)

  • 1. Can intravitreal ranibizumab alter retrobulbar circulation in eyes with age-related macular degeneration?
    Yuksel K; Altinkaynak H; Kina A; Kara N; Yazici AT; Demirok A
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):723-7. PubMed ID: 23829173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration.
    Hosseini H; Lotfi M; Esfahani MH; Nassiri N; Khalili MR; Razeghinejad MR; Nouri-Mahdavi K
    Retina; 2012 May; 32(5):967-71. PubMed ID: 22146127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of retrobulbar blood flow by color doppler ultrasonography after intravitreal ranibizumab injection in patients with neovascular age-related macular degeneration.
    Sakalar YB; Senturk S; Yildirim M; Keklikci U; Alakus MF; Unlu K
    J Clin Ultrasound; 2013 Jan; 41(1):32-7. PubMed ID: 23055187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does ranibizumab (Lucentis®) change retrobulbar blood flow in patients with neovascular age-related macular degeneration?
    Mete A; Saygili O; Mete A; Gungor K; Bayram M; Bekir N
    Ophthalmic Res; 2012; 47(3):141-5. PubMed ID: 22042133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravitreal aflibercept (Eylea
    Gok M; Kapti HB
    Int Ophthalmol; 2018 Apr; 38(2):713-719. PubMed ID: 28421399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of intravitreal bevacizumab (Avastin(®)) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration.
    Toklu Y; Cakmak HB; Raza S; Anayol A; Asik E; Simşek S
    Acta Ophthalmol; 2011 Feb; 89(1):e41-5. PubMed ID: 21232081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration.
    Mete A; Saygili O; Mete A; Bayram M; Bekir N
    J Clin Ultrasound; 2010 Feb; 38(2):66-70. PubMed ID: 19953626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Effect of Intravitreal Ranibizumab on Retrobulbar Hemodynamics by Color Doppler Ultrasonography in Neovascular AMD.
    Raza S; Ergun SB; Toklu Y; Cakmak HB; Ipek A; Cagil N
    Ophthalmic Surg Lasers Imaging Retina; 2019 Jul; 50(7):437-443. PubMed ID: 31344243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound assessment of ocular vascular effects of repeated intravitreal injections of ranibizumab for wet age-related macular degeneration.
    Bonnin P; Pournaras JA; Makowiecka K; Krivosic V; Kedra AW; Le Gargasson JF; Gaudric A; Levy BI; Cohen YS; Tadayoni R; Massin P
    Acta Ophthalmol; 2014 Aug; 92(5):e382-7. PubMed ID: 25043792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroidal Thickness Changes After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.
    Minnella AM; Federici M; Falsini B; Barbano L; Gambini G; Lanza A; Caporossi A; Savastano MC
    BioDrugs; 2016 Aug; 30(4):353-9. PubMed ID: 27189458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravitreal bevacizumab on retrobulbar blood flow of patients with diabetic macular edema.
    Örnek N; Inal M; Erbahceci IE; Oğurel T; Örnek K
    Eur J Ophthalmol; 2015; 25(6):539-45. PubMed ID: 25907286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration.
    Cekiç O; Bardak Y; Yeşildağ A
    Curr Eye Res; 2011 Feb; 36(2):149-53. PubMed ID: 21158585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal blood flow in response to an intravitreal injection of ranibizumab for neovascular age-related macular degeneration.
    Micieli JA; Tsui E; Lam WC; Brent MH; Devenyi RG; Hudson C
    Acta Ophthalmol; 2012 Feb; 90(1):e13-20. PubMed ID: 21801339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of photodynamic therapy on retrobulbar blood flow parameters.
    Türkçüoğlu P; Deniz N; Koç M; Kurt J; Celiker U
    Clin Exp Ophthalmol; 2008; 36(1):39-42. PubMed ID: 18190598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
    Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
    Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intravitreal triamcinolone acetonide versus intravitreal bevacizumab on retrobulbar hemodynamic in patients with diabetic macular edema.
    Shahin M; Gad MA; Hamza W
    Cutan Ocul Toxicol; 2014 Mar; 33(1):49-53. PubMed ID: 23742103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion.
    Sacu S; Pemp B; Weigert G; Matt G; Garhofer G; Pruente C; Schmetterer L; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3046-50. PubMed ID: 21051706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.